FRA:GIS • US3755581036
This GIS.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
GIS gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 75 industry peers in the Biotechnology industry. Both the health and profitability get an excellent rating, making GIS a very profitable company, without any liquidiy or solvency issues. GIS is not valued too expensively and it also shows a decent growth rate. These ratings would make GIS suitable for quality investing!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.42% | ||
| ROE | 37.49% | ||
| ROIC | 19.49% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 39.98% | ||
| PM (TTM) | 28.9% | ||
| GM | 78.83% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 2.64 | ||
| Altman-Z | 4.62 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.4 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.18 | ||
| Fwd PE | 16.61 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.44 | ||
| EV/EBITDA | 13.49 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.28% |
FRA:GIS (3/4/2026, 5:00:31 PM)
127.63
+1.33 (+1.05%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.28% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.18 | ||
| Fwd PE | 16.61 | ||
| P/S | 6.24 | ||
| P/FCF | 19.44 | ||
| P/OCF | 18.34 | ||
| P/B | 8.1 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.49 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.42% | ||
| ROE | 37.49% | ||
| ROCE | 24.94% | ||
| ROIC | 19.49% | ||
| ROICexc | 25.18% | ||
| ROICexgc | 81.81% | ||
| OM | 39.98% | ||
| PM (TTM) | 28.9% | ||
| GM | 78.83% | ||
| FCFM | 32.11% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 2.64 | ||
| Debt/EBITDA | 1.52 | ||
| Cap/Depr | 20.4% | ||
| Cap/Sales | 1.91% | ||
| Interest Coverage | 11.36 | ||
| Cash Conversion | 68.94% | ||
| Profit Quality | 111.11% | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 4.62 |
ChartMill assigns a fundamental rating of 7 / 10 to GIS.DE.
ChartMill assigns a valuation rating of 6 / 10 to GILEAD SCIENCES INC (GIS.DE). This can be considered as Fairly Valued.
GILEAD SCIENCES INC (GIS.DE) has a profitability rating of 9 / 10.
The financial health rating of GILEAD SCIENCES INC (GIS.DE) is 8 / 10.
The Earnings per Share (EPS) of GILEAD SCIENCES INC (GIS.DE) is expected to grow by 9.44% in the next year.